EP3421039
DRUG FOR CANCER THERAPY CHARACTERIZED BY ADMINISTERING COMBINATION BETWEEN AXL INHIBITOR AND IMMUNE CHECKPOINT INHIBITOR
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
24.2.2017EP published:
6.10.2021EP application number:
17756670.0
EPO information:
European Patent Register
Max expiry date:
23.2.2037
Title:
DRUG FOR CANCER THERAPY CHARACTERIZED BY ADMINISTERING COMBINATION BETWEEN AXL INHIBITOR AND IMMUNE CHECKPOINT INHIBITOR
Timeline
Today
24.2.2017EP application
6.10.2021EP Publication
Owner
Name:
ONO Pharmaceutical Co., Ltd.Address:
1-5, Doshomachi 2-chome Chuo-ku, Osaka-shi, Osaka 541-8526, JP
Inventor
Name:
TANAKA, KoheiAddress:
Mishima-gun Osaka 618-8585, JP
Name:
YASUHIRO, TomokoAddress:
Mishima-gun Osaka 618-8585, JP
Priority
Number:
2016035206Date:
26.2.2016Country:
JP
Classification
Categories:
A61K 31/4709, A61K 39/395, A61K 45/00, A61P 35/00, A61P 43/00, C07K 16/18